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http://www.biomedcentral.com/1471-2474/14/85RESEARCH ARTICLE Open AccessAllelic expression analysis of the osteoarthritis
susceptibility gene COL11A1 in human joint
tissues
Emma V A Raine, Andrew W Dodd, Louise N Reynard and John Loughlin*Abstract
Background: The single nucleotide polymorphism (SNP) rs2615977 is associated with osteoarthritis (OA) and is
located in intron 31 of COL11A1, a strong candidate gene for this degenerative musculoskeletal disease.
Furthermore, the common non-synonymous COL11A1 SNP rs1676486 is associated with another degenerative
musculoskeletal disease, lumbar disc herniation (LDH). rs1676486 is a C-T transition mediating its affect on LDH
susceptibility by modulating COL11A1 expression. The risk T-allele of rs1676486 leads to reduced expression of the
COL11A1 transcript, a phenomenon known as allelic expression imbalance (AEI). We were keen therefore to assess
whether the effect that rs1676486 has on COL11A1 expression in LDH is also observed in OA and whether the
rs2615977 association to OA also marked AEI.
Methods: Using RNA from OA cartilage, we assessed whether either SNP correlated with COL11A1 AEI by 1) measuring
COL11A1 expression and stratifying the data by genotype at each SNP; and 2) quantifying the mRNA transcribed
from each allele of the two SNPs. We also assessed whether rs1676486 was associated with OA susceptibility using
a case–control cohort of over 18,000 individuals.
Results: We observed significant AEI at rs1676486 (p < 0.0001) with the T-allele correlating with reduced COL11A1
expression. This corresponded with observations in LDH but the SNP was not associated with OA. We did not
observe AEI at rs2615977.
Conclusions: COL11A1 is subject to AEI in OA cartilage. AEI at rs1676486 is a risk factor for LDH, but not for OA.
These two diseases therefore share a common functional phenotype, namely AEI of COL11A1, but this appears to
be a disease risk only in LDH. Other functional effects on COL11A1 presumably account for the OA susceptibility
that maps to this gene.
Keywords: Osteoarthritis, Lumbar disc herniation, Genetics, Susceptibility, COL11A1, Allelic expressionBackground
Primary osteoarthritis (OA) is a common disease of
the synovial joint characterised by articular cartilage
thinning and loss, which is often accompanied by al-
teration in the normal function of other tissues of
the joint [1]. A number of epidemiological studies
have demonstrated that osteoarthritis has a major
genetic component, although elucidation of this has
proven challenging [2].* Correspondence: john.loughlin@ncl.ac.uk
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reproduction in any medium, provided the orGenome-wide association scans (GWASs) are now
being employed as a powerful, objective tool for map-
ping OA susceptibility loci [3-6]. In some circum-
stances the resulting signals are to regions of the
genome that do not harbour obvious OA candidates,
whereas in others the signals are close to, or even
within, a gene that would be considered a strong can-
didate. One example of the latter emerged from the
original arcOGEN GWAS [4]. This GWAS and its
subsequent replication analysis was performed on in-
dividuals of European descent and included the full
arcOGEN samples and, amongst other signals, identi-
fied association to single nucleotide polymorphismtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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odds ratio of 1.10 for the T-allele of the SNP.
rs2615977 resides within intron 31 of COL11A1.
This gene codes for the α1 polypeptide chain of type
XI collagen, a quantitatively minor but structurally
important component of the cartilage extracellular
matrix. Mutations within COL11A1, typically involv-
ing the substitution of highly conserved glycine resi-
dues or the deletion of whole exons, are responsible
for certain forms of Stickler syndrome, a rare and
usually dominant Mendelian condition that presents
with a severe and premature form of OA manifesting
during adolescence [7,8].
Lumbar disc herniation (LDH) and lumbar disc de-
generation (LDD) can be viewed as having similar
aetiological routes to OA, with each condition being
age-associated and involving the degeneration of cartil-
age, albeit of different types, with OA being hyaline
and LDH/LDD being fibrocartilage. The common non-
synonymous SNP rs1676486, which is located in exon
62 of COL11A1, has been reported to associate with
LDH in a Japanese population [9]. rs1676486 is a C-T
transition that results in a proline to serine substitu-
tion. Using an in vitro assay the investigators were able
to demonstrate that the LDH-associated T-allele of
rs1676486 correlated with decreased stability of the
COL11A1 transcript relative to the C-allele. Such a differ-
ence in allelic expression, whether mediated by differen-
tial mRNA transcription or mRNA transcript stability, is
known as allelic expression imbalance (AEI). As such,
the investigators concluded that a quantitative deficiency
of COL11A1, and by extrapolation a quantitative defi-
ciency of the α1 polypeptide chain of type XI collagen,
was a contributor to LDH susceptibility.
As more susceptibility loci are identified for common
human diseases it is becoming clear that many, if not the
majority, of associated alleles contribute to disease risk
by influencing gene expression, typically by modulating
rates of transcription or transcript stability [10,11]. The
T-allele of rs1676486 is an example of such an effect in
LDH. It is also becoming apparent that in most of these
cases the effect that the susceptibility allele has on the tran-
script can be organ, tissue or even cell type-specific [12,13].
It is important therefore to study RNA extracted from tis-
sues relevant to the disease of interest when assessing the
potential effect of a functional susceptibility allele.
Based on these observations we hypothesised that the
OA association to COL11A1, marked by rs2615977, may
be mediated by modulating the expression of the gene in
articular cartilage. In addition, we hypothesised that the
effect that rs1676486 has on COL11A1 expression in
LDH may also be observed in OA. To investigate these
hypotheses we have quantitatively measured overall ex-
pression of COL11A1 in cartilage and then stratified ourdata by genotype at rs2615977 and at rs1676486. We
have also tested for AEI of COL11A1 using assays that
can accurately discriminate and quantify the mRNA out-
put from each allele of a transcript SNP.
Methods
Patients and tissues
Macroscopically normal articular cartilage tissue located
away from the OA lesion was obtained from individuals
undergoing elective joint replacement for OA of the hip
(total hip replacement, THR) or of the knee (total knee
replacement, TKR), as described in detail previously
[14,15]. The Newcastle and North Tyneside research eth-
ics committee granted ethical approval for the collection
(REC reference number 09/H0906/72) and written in-
formed consent was obtained from donors for the use of
their tissue, and permission for publication of their age
and sex. Details regarding the patients can be found in
Additional file 1: Table S1 and Additional file 2: Table S2.
Nucleic acid extraction
On the day of surgery, the tissue specimens were snap-
frozen at −80°C. For each individual tissue sample, 0.5-
1.0 g of frozen tissue was ground to a powder using a
Retsch mixermill 200 (Retsch Limited, Leeds, UK) under
liquid nitrogen, which causes the sample to become brit-
tle and prevents the RNA from degrading. Genomic
DNA and RNA were then extracted from the ground
tissue samples using an EZNA DNA/RNA Isolation Kit
and a protocol established for human tissue (Omega
bio-tek, R6731-02). The nucleic acid was quantified using
a NanoDrop ND-1000 Spectrophotometer (NanoDrop
Technologies, Wilmington, USA).
SNPs
We studied three COL11A1 SNPs: the OA associated
SNP rs2615977, which is located in intron 31; the LDH
associated SNP rs1676486, which is located in exon 62;
and SNP rs9659030, which is located in the 30UTR
(Table 1). rs9659030 was analysed for AEI in the absence
of a COL11A1 transcript SNP in high linkage disequilib-
rium (LD) with the OA SNP rs2615977. rs2615977 is
98.2 kb from rs1676486 and 110 kb from rs9659030.
SNP genotyping
The three COL11A1 SNPs were genotyped by restriction
fragment length polymorphism (RFLP) analysis (patient
genotypes are listed in Additional file 1: Table S1). The
primer sequences and restriction enzymes used can be
found in Additional file 3: Table S3.
cDNA synthesis and quantitative real-time PCR
RNA extracted from cartilage was reverse transcribed
using the SuperScript First-Strand cDNA synthesis kit
Table 1 The three COL11A1 SNPs studied in this report
SNP Alleles MAF1 Pairwise linkage disequilibrium
Relative to rs2615977 Relative to rs1676486 Relative to rs9659030
D0 r2 D0 r2 D0 r2
rs2615977 T/G 0.239 - - 0.58 0.03 0.39 0.08
rs1676486 C/T 0.202 0.58 0.03 - - 0.33 0.09
rs9659030 A/G 0.173 0.39 0.08 0.33 0.09 - -
1Minor allele frequency in Europeans (HapMap CEU).
Raine et al. BMC Musculoskeletal Disorders 2013, 14:85 Page 3 of 8
http://www.biomedcentral.com/1471-2474/14/85(Invitrogen). Gene expression was measured by quan-
titative real-time PCR using PrimeTime Mini qPCR
Assays (Integrated DNA Technologies, Iowa, USA)
and an ABI PRISM 7900HT Sequence Detection Sys-
tem (Applied Biosystems). COL11A1 expression was
measured relative to the average expression of the
housekeeping genes HPRT1, GAPDH and 18S: for
each cDNA sample three pipetting replicates we
performed per gene and the nine housekeeper cycle
threshold (Ct) values (3x3) were combined to derive
the mean Ct which was used as the control to compare
against COL11A1. Expression of COL11A1 relative to
the housekeepers was determined using the 2-Δ Ct
method. Mann–Whitney U and Kruskal-Wallis tests
were performed to assess whether COL11A1 expression
relative to genotype at rs2615977 and genotype at
rs1676486 differed significantly from the null. All pri-
mer and probe sequences can be found in Additional
file 4: Table S4.
AEI analysis
AEI was assessed using the transcript SNPs rs1676486
and rs9659030 and quantitative real time PCR geno-
typing assays, purchased from Applied Biosystems.
These assays are standard real time assays except that
they employ a probe (labeled with FAM or VIC) spe-
cific to each of the two alleles of a SNP. Real time
PCR was carried out according to the manufacturer’s
instructions. In brief, 10 ng of cDNA or 20 ng of
DNA extracted from the cartilage was added to 5 μl
of TaqMan Universal Master Mix II no UNG (Applied
Biosystems) and 0.25 μl of 40 × TaqMan assay in a
10 μl reaction. The samples were then amplified on
an ABI PRISM 7900HT Sequence Detection System.
The reactions were performed with five pipetting rep-
licates and the allelic ratios were calculated using the
formula (2-FAM Ct)/(2-VIC Ct).
For each assay, the ratios between the amounts of
each allele in every sample were calculated for genomic
DNA and cDNA. For each sample the average allelic
ratio for genomic DNA, which represents the 1:1 ratio,
was then used to normalise the cDNA ratio to generate
a corrected allelic ratio. To determine if there was an
overall difference in expression between alleles for aparticular tissue across all patients the mean allelic ra-
tios for the patient cDNAs were compared to the mean
allelic ratios for the patient genomic DNAs using a
Mann–Whitney U test.
Quality control checks on the AEI assays
The capacity for each assay to discriminate between
SNP alleles was verified using a standard curve of artifi-
cially created allelic ratios using DNA from samples
homozygous for the major and the minor alleles. To as-
sess the amplification efficiency of each AEI probe (two
per assay) a standard curve was produced by performing
AEI on a serial dilution of 200 ng to 1.5635 ng of DNA
from a heterozygous sample.
Association of rs1676486 with OA
We analysed the LDH associated SNP rs1676486 for evi-
dence of association to OA using data from the UK
arcOGEN study. This is a GWAS performed for 485,491
autosomal SNPs and conducted on 7,410 cases with se-
vere OA of the hip or the knee, 80% of whom had
undergone total joint replacement, and on 11,009 publi-
cally available population controls [6].
Results
Quantitative expression of COL11A1 in cartilage stratified
by genotype at the OA and LDH associated SNPs
To initially assess the degree to which rs2615977 and
rs1676486 correlate with expression of COL11A1, we
used quantitative real-time PCR to measure the level
of expression of the gene in cDNA that had been
synthesised from cartilage RNA. We then stratified
the data by genotype at rs2615977 and by genotype
at rs1676486 (Figure 1). Only one patient was homo-
zygous for the minor allele of rs1676486. This is a
reflection of the low frequency of TT homozygotes
for this SNP, with a frequency of only 1.8% reported
in HapMap CEU. As such, for this SNP a compari-
son was made between those patients who carry the
LDH risk T-allele and those who do not, that is, be-
tween CC homozygotes versus CT heterozygotes and
TT homozygotes combined. There was no significant
correlation (p < 0.05) between the level of COL11A1
expression and the genotype at either rs2615977 or
Figure 1 Columnar scatter plot of the quantitative expression of COL11A1 in cartilage cDNA stratified by genotype at A) the OA
associated SNP rs2615977 and B) the LDH associated SNP rs1676486. Due to the low frequency of TT homozygotes at rs1676486 the
analysis in B) was between CC homozygotes and T-allele carriers (CT and TT combined) at this SNP. n is the number of patients studied for each
group. The horizontal lines in each plot represent the mean and the standard error of the mean. P-values were calculated using a Kruskal-Wallis
test for A) and a Mann–Whitney U test for B).
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into those who had undergone TKR and those who
had undergone THR, and repeated the analysis. Again,
there was no correlation between COL11A1 expression
and genotype at either SNP (Figure 2).Figure 2 Columnar scatter plots of the quantitative expression of CO
associated SNP rs1676486 in knee cases, B) genotype at the LDH asso
associated SNP rs2615977 in knee cases, and D) genotype at the OA
TT homozygotes at rs1676486 the analysis in A) and B) was between CC h
Due to the absence in the hip strata of GG homozygotes at rs2615977 the
this SNP. n is the number of patients studied for each group. The horizonta
mean. P-values were calculated using a Mann–Whitney U test for A), B) anAEI analysis
The above analysis did not provide evidence for a correl-
ation between COL11A1 expression and genotype at
rs2615977 or genotype at rs1676486. However, this tech-
nique is vulnerable to the natural fluctuation in geneL11A1 in OA cartilage cDNA stratified by A) genotype at the LDH
ciated SNP rs1676486 in hip cases, C) genotype at the OA
associated SNP rs2615977 in hip cases. Due to the low frequency of
omozygotes and T-allele carriers (CT and TT combined) at this SNP.
analysis in D) was between TT homozygotes and TG heterozygotes at
l lines in each plot represent the mean and the standard error of the
d D) and a Kruskal-Wallis test for C).
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curacy [16]. For example, it is apparent from
Figures 1 and 2 that between individuals of the same
genotype the expression of COL11A1 can vary by
greater than 200 fold. As such, quantitative PCR can
generate false negative results when used in this
manner. An alternative method for correlating geno-
type with expression levels that is not vulnerable to
such fluctuation is allelic expression imbalance, ab-
breviated to AEI and also known as differential allelic
expression. This entails using a transcript SNP to dif-
ferentiate and measure the cDNA output from the
two alleles of a heterozygote. Genomic DNA is used
as the comparator control to provide the 1:1 ratio to
which the cDNA allelic ratio is compared. We there-
fore assessed whether COL11A1 demonstrated AEI
and if so, whether this correlated with genotype at
rs2615977 or at rs1676486.
rs1676486 is a transcript SNP and it could itself be
used in the AEI analysis. However, rs2615977 is intronic
and could not be used. A search of the Ensembl data-
base (http://www.ensembl.org/) for COL11A1 transcript
SNPs in high LD (r2 > 0.5) with rs2615977 identified only
two SNPs, which happen to be in perfect LD (r2 = 1,
D0 = 1) with the SNP: rs1012281 and rs1012282, both
within exon 45. However, according to the UCSC data-
base (http://genome.ucsc.edu/), the sequence harbouring
these SNPs is not part of the COL11A1 transcript. To re-
solve this discrepancy we amplified across the region
using OA cartilage cDNAs and genomic DNAs as tem-
plates. The same primers were used for the two tem-
plates and we successfully amplified DNA but we failed
to detect a cDNA product (results not shown). We con-
cluded therefore that the UCSC database was accurate
and that rs1012281 and rs1012282 are not transcript
SNPs and could not therefore be used. Since there are
no transcript SNPs in high LD with rs2615977 we opted
to use a transcript SNP that had a high heterozygosity
value, thus ensuring that a large number of our patients
would be informative for the AEI analysis if we focused
on individuals who were compound heterozygotes for
rs2615977 and the transcript SNP. Due to the small size
of the majority of COL11A1 exons we needed to avoid a
transcript SNP that was close to an intron/exon bound-
ary, as this would not allow us to use the same primers
and probe when targeting cDNA and DNA in our AEI
analysis. The transcript SNP that we chose was the
30UTR SNP rs9659030, which has a heterozygosity value
of 0.31 in Europeans and is over 350 bp from the nearest
exon boundary. Although rs9659030 is not in LD with
rs2615977 (pair wise r2 = 0.08, pair wise D0 = 0.40), by
studying compound heterozygotes we were able to use
rs9659030 to functionally separate the two rs2615977 al-
leles. Although we could not determine phase betweenrs2615977 and rs9659030 we would expect a high pro-
portion of the compound heterozygotes to demonstrate
AEI if rs2615977 is itself, or if it correlates with, a
polymorphism that influences gene expression at an al-
lelic level.
rs1676486
We carried out AEI analysis on 22 OA patients hetero-
zygous for the LDH SNP rs1676486, all of whom
showed a significant (p < 0.05) decrease in expression of
the T-allele relative to the C-allele with an average al-
lelic ratio of 0.36 (p < 0.0001) (Figure 3 and Additional
file 5: Table S5). That is, for every one C-allele cDNA
molecule there were only 0.36 cDNA molecules of a
T-allele. It was the T-allele of rs1676486 that showed
reduced stability in the original LDH study [9]. Our
functional data therefore supported the functional data
from the LDH study.
rs9659030
We carried out AEI analysis on 26 OA patients hetero-
zygous for rs9659030 (Figure 4 and Additional file 5:
Table S5). Thirteen of the 26 were compound heterozy-
gous for rs2615977 and rs9659030 but only one of the
13, patient 20, showed a significant AEI. The two alleles
of the OA associated SNP rs2615977 do not therefore
correlate with differences in expression of COL11A1. In
addition to patient 20 three other patients also showed a
significant AEI (patients 13, 37 and 39 in Figure 4).
These three patients were not heterozygous at
rs2615977 but they were heterozygous for the LDH SNP
rs1676486 and it is presumably this that accounts for
the AEI observed in these patients.
We were intrigued to note that the further nine
patients who were also compound heterozygous for
rs1676486 and rs9659030 did not demonstrate sig-
nificant AEI when their allelic expression was mea-
sured using rs9659030 (patients 1, 3, 8, 10, 11 24,
31, 46 and 76 in Figure 4) - based on the AEI re-
sults for rs1676486 reported earlier we had antici-
pated that all nine would have demonstrated
significant AEI with rs9659030, particularly in light
of the fact that eight of the nine had been tested
with rs1676486 and had shown significant AEI with
this SNP (patients 1, 3, 8, 10, 11, 24, 31 and 46 in
Figure 3). Quality control (QC) checks on the
rs9659030 AEI assay revealed that it is able to accur-
ately discriminate between and measure differences
in the levels of the two alleles of this SNP (Add-
itional file 6: Figure S1) and that this capacity is well
within the range of AEI observed at rs1676486. For
example, the average rs1676486 C/T ratio for the 22
patients of Figure 3 and Additional file 5: Table S5
was 0.36 and it is clear from Additional file 6: Figure
Figure 3 Allelic expression analysis in cartilage samples from OA patients assessed using the LDH associated SNP rs1676486. The
genotypes of the patients at rs1676486, at the OA associated SNP rs2615977 and at the 30UTR SNP rs9659030 are shown. P-values were calculated
by comparing the cDNA allelic ratio to the DNA allelic ratio using a Mann–Whitney U test. ** denotes p < 0.01.
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have detected such a difference if it existed at this
SNP. These QC checks confirm that the rs9659030
AEI assay is robust. Overall, these results imply that
there is variation in the degradation rate of the
COL11A1 transcript across its length, which would
mean that the AEI results obtained could partly be
dependent on the physical position in the transcript
of the SNP used to measure AEI.Figure 4 Allelic expression analysis in cartilage samples from OA pati
the patients at rs9659030, at the OA associated SNP rs2615977 and at the L
comparing the cDNA allelic ratio to the DNA allelic ratio using a Mann–WhGenetic association analysis of rs1676486 with OA
We finally assessed whether rs1676486 was associated to
OA using the arcOGEN GWAS dataset. This revealed
that the SNP showed only marginal evidence of associ-
ation, with a p-value of 0.012 in the comparison of 7,410
cases and 11,009 controls (Additional file 7: Table S6).
The association signal was in the same direction as seen
for the Japanese LDH study, in that it was the T-allele of
rs1676486 that was elevated in cases (frequency of 0.201)ents assessed using the 30UTR SNP rs9659030. The genotypes of
DH associated SNP rs1676486 are shown. P-values were calculated by
itney U test. ** denotes p < 0.01.
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of 1.069 (95% confidence interval of 1.015-1.127). Strati-
fication of the arcOGEN data by site of OA (hip or knee)
did not enhance the association signal (Additional file 7:
Table S6) nor was there a more significant signal when
the data was stratified by sex, or by sex combined with
site (data not shown).
Discussion
Allelic expression imbalance (AEI) has been shown to be
an important mechanism through which OA susceptibil-
ity acts, with an excellent example being the SNP
rs143383 located in the 50UTR of the growth differenti-
ation factor 5 gene GDF5; this SNP is robustly associated
with knee OA across various ethnic groups, with the
OA-associated T-allele of the polymorphism mediating
reduced expression of GDF5 in cartilage and other joint
tissues [reviewed in 2]. Based on observations such as this,
we were keen to assess whether the COL11A1 OA associ-
ation, marked by rs2615977, also correlated with AEI in
OA cartilage. A previously published study of LDH dem-
onstrated that this gene was subject to AEI and we there-
fore also assessed whether the LDH SNP rs1676486
correlated with AEI in OA cartilage and if so, whether the
polymorphism was genetically associated with the disease.
Our results did not provide evidence for a correlation
between the OA associated SNP rs2615977 and
COL11A1 AEI but they did provide compelling evidence
for a correlation between the LDH associated SNP
rs1676486 and AEI at this gene. As for LDH, it was the
T-allele of rs1676486 that correlated with reduced ex-
pression of COL11A1. However, the polymorphism dem-
onstrated only very weak evidence of association with
OA and as this association data derives from a GWAS of
over 480,000 SNPs, the very moderate p-value does not,
in our view, support rs1676486 as an OA susceptibility
locus despite its functional effect. From our rs1676486
data we therefore conclude that in the cartilage of OA
patients who have undergone elective hip or knee joint
replacement surgery, COL11A1 is subject to AEI, but that
this is not a risk factor for OA. Mature hyaline cartilage
tissue is therefore resilient to such COL11A1 allelic im-
balance effects, unlike the fibrocartilage of LDH, which is
vulnerable to COL11A1 AEI.
The lack of a correlation between the OA associated
SNP rs2615977 and COL11A1 expression implies that the
association marked by this SNP is operating by a route
other than an effect on the expression of the gene in ma-
ture cartilage. However, it is possible that we failed to de-
tect any such correlation, since in our AEI analysis we used
a SNP, rs9659030, that is not physically close to rs2615977.
After all, our comparison of AEI in individuals compound
heterozygous for rs9659030 and rs1676486 did imply that
AEI may not be uniform across the COL11A1 transcript.However, the fact that AEI in mature cartilage as mea-
sured with rs1676486 is not an OA risk factor makes it
seem unlikely that the OA risk marked by rs2615977
would be operating via this mechanism in this tissue. It
is possible that rs2615977, or a SNP in high LD with it,
is modulating the expression of COL11A1 at time points
not studied here, for example during skeletogenesis or in
adolescent tissues. Of possible relevance to this is the
presence in the ENCODE database [17] of SNP
rs11164648, which is in perfect LD with rs2615977 and
which is located within a CTCF-binding site that is pre-
dicted to act as a transcriptional insulator. CTCF is a
transcriptional repressor and CTCF-dependent insulators
have been shown to regulate gene expression by modulat-
ing chromatin conformation during development [18]. If
cartilage tissues were to become available from an ad-
equate number of young donors then assessing COL11A1
AEI relative to genotype at rs2615977 or rs11164648 may
be insightful.
As noted in the introduction, Stickler syndrome is a
rare and usually dominant condition presenting with a
severe and early onset form of OA [7,8]. Stickler syn-
drome can present with a high degree of inter and
intra-familial variability and as such it may be of bene-
fit to assess whether the possession of the low express-
ing T-allele of rs1676486, which we have shown is
functionally active in cartilage and which has a fre-
quency of >20% in Europeans and Asians, correlates in
any way with this phenotypic heterogeneity; possessing
a low expressing COL11A1 allele alongside a mutant
allele may exacerbate the phenotype whilst if the mu-
tant COL11A1 allele is on a low-expressing allele then
this could attenuate the phenotype.
Conclusions
Overall our study has identified that COL11A1 AEI is
common to both LDH and OA, but that it is not a risk
factor for OA. Presumably other functional effects must
be accounting for the OA associated signal at this gene.
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Additional file 1: Table S1. Table of patient characteristics and their
genotype at the three COL11A1 SNPs studied in this report. F, female; M,
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patients studied.
Additional file 3: Table S3. Table of primers and enzymes used for
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for quantitative PCR analysis of COL11A1.
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the standard error of the mean. P-values were calculated using a Mann
Whitney U test. P-values < 0.05 are highlighted in bold.
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